{"nct_id":"NCT03767543","title":"Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)","status":"COMPLETED","status_verified_date":"2022-04","start_date":"2019-03-11","start_date_type":"ACTUAL","primary_completion_date":"2020-10-23","primary_completion_date_type":"ACTUAL","completion_date":"2020-10-23","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}